INTRODUCTION
Liver transplantation is the most acceptable treatment for patients with end-stage liver diseases. However, despite a rapid development in surgical technology and postoperative therapy, vascular complications are still significant problems that threaten survival after liver transplantation (1-3). The overall incidence of vascular complications is reported at around 7% in patients who receive deceased donor liver transplantation and approximately 13% in patients with a living donor liver transplantation (4) (5) (6) . Complications that affect the hepatic artery and portal vein are the most common after transplantation (7, 8) . Hepatic artery thrombosis (HAT) is the most severe and fatal hepatic artery complication, the incidence is 3-5% and the fatality rate is 20-60% (9, 10) . Portal vein thrombosis (PVT) and portal vein stenosis (PVS) are also adverse vascular complications that damage liver function and threaten the survival of recipients, the incidence is 1-12.5% (10, 11) . Thus, early diagnosis of vascular complications is crucial for the management of disease and patients survival.
Clinical signs and proof of vascular complications are always non-specific and ambiguous and diagnosis frequently relies on imaging findings. Angiography is still regarded as the gold standard for the assessment of vascular complications.
Computed tomography (CT) is another effective method to diagnose complications.
These techniques are not ideal for routine screening after liver transplantation due to the disadvantages of the use of ionizing radiation or nephrotoxic contrast media, high costs and the difficulty to perform this technique at the bedside. Ultrasound (US) is preferred for the detection of vascular complications in the early postoperative period and long-term follow-up as it is a non-invasive, non-radioactive and cost-effective technique that can be performed at the bedside (12, 13) . Previous studies have shown the good sensitivity of doppler US (75-100%) for the detection of vascular complications (14) (15) (16) . However, the aliasing or overwriting artifacts and other limiting factors of US examination may result in a misdiagnosis or inconclusive diagnosis. Thus, contrast-enhanced ultrasound (CEUS) has been established as a routine clinical measurement for liver transplant recipients as it overcomes the limitations of angiography, CT and US imaging. CEUS can be applied to evaluate microcirculation of the liver graft and to facilitate visualization of blood vessels, providing real-time angiographic-like images with a high diagnostic efficiency (17) .
Moreover, CEUS seldom causes adverse reactions and can be used in patients with renal insufficiency. This is due to the fact that ultrasound contrast agents have a low incidence of allergic reactions which only occurs in one out of ten thousand cases, according to previous studies (18, 19) . Prior studies have revealed a relatively high accuracy (> 90%) of CEUS for the diagnosis of postoperative vascular complications including HAT, HAS, PVT and PVS (10, 20, 21 ). However, these individual studies only involved a limited number of patients and therefore, the actual diagnostic value of CEUS could not be determined.
Thus, the present systematic review and meta-analysis aimed to assess the diagnostic performance of CEUS for monitoring postoperative vascular complications in patients after liver transplantation via the analysis of all available data.
MATERIALS AND METHODS

Literature search
PubMed, EMBASE, ScienceDirect and Web of Science databases were used to identify articles that investigated the usefulness of CEUS for the detection of vascular complications after liver transplantation. The applied search terms included the following: contrast-enhanced, ultrasound or ultrasonography, vascular complications or hepatic artery or portal vein, liver transplantation or postoperative and all the possible combinations. The search was limited to studies published no later than the 28 th of February of 2018. Two authors screened all the titles and abstracts of the potential studies for eligibility criteria. Articles relevant to the topic were retrieved and the full-text was reviewed. The reviewers subsequently searched manually all the citations of the retrieved studies and other relevant review articles for additional publication that did not appear in the initial search.
Inclusion and exclusion criteria
Studies were included if they met the following criteria: a) the study population Articles that did not satisfy the above criteria, review studies, letters, case reports, comments, unpublished material, conference abstracts and multiple reports published on the same cohort were excluded. The corresponding author of the articles was contacted for information for relevant studies that did not provide the necessary data for analysis. If we did not receive a response from the author within two weeks, the study was excluded from the meta-analysis.
Data extraction and quality assessment
Two reviewers independently extracted and recorded data according to a predefined form for each report. all discrepant issues and the majority opinion was used for analysis.
The methodological quality of each included study was assessed via the quality assessment of diagnostic accuracy study form (QUADAS-2), which is a revised quality assessment appliance developed explicitly for a meta-analysis of diagnostic accuracy studies. The quality of primary diagnostic studies was assessed via an estimation of the risk of bias of four domains and clinical applicability of three domains of the study characteristics (22) .
Statistical analysis
The Stata version 15.0 (Stata Corporation, College Station, TX, USA) and Meta-DiSc 
RESULTS
Study selection
Three hundred and seventy potential citations were identified for inclusion into the study via multiple database searches and cross-checking of reference lists. Thirty-five articles were potentially relevant according to their titles and abstracts. After reviewing the full text, 12 were further excluded due to duplication (n = 2), nonassessment of vascular complications (n = 3) and insufficient data to create the 2 x 2 contingency table (n = 7). Eventually, 13 studies that consisted of 2,781 cases of CEUS evaluations were enrolled into the meta-analysis. A flow chart of published study selection is presented in figure 1 .
Study characteristics
Relevant data extracted from all 13 studies are summarized in radiologists with more than four years of experience in CEUS evaluations of the liver.
All the enrolled studies used a SonoVue (Bracco, Milan, Italy) contrast agent.
Information about the local contrast protocol including timing of CUES evaluation, the ultrasound devices used and dose of CEUS contrast agent are presented in table   1 .
Quality assessment
The quality assessment of the 13 studies was moderate based on the QUADAS-2 items. The detailed information of each included study and the results of the distribution are presented in figure 2 .
Diagnostic accuracy
The sensitivity and specificity with 95% CI of each study are displayed as forest plots in figure 3A . The pooled weighted values of CEUS were a sensitivity of 0.90 (95% CI, 0.84 to 0.95), a specificity of 1.00 (95% CI, 1.00 to 1.00) and a DOR of 431.96 (95% CI, 164.60 to 1,133.59) (Fig. 3B) . The AUC of SROC was 0.9741 ± 0.0136, which was very close to a perfect performance and the *Q index was 0.9267 ± 0.0232 (Fig. 3C ). There was no evidence of a publication bias among the included studies according to the Deeks funnel plot asymmetry analysis (p = 0.11).
The sensitivity analysis stratified subgroups into different ages, study design and sample sizes as the present meta-analysis included studies with varied characteristics. Only the study by Bonini (23) (Table 2) .
Heterogeneity text
The statistical analysis resulted in an I 2 of 40.3% for sensitivity analysis and I 2 of 32.6%
for specificity. Although heterogeneity was not significant, it was still considered as moderate among the studies. Thus, threshold effect testing was also performed. The
Spearman's correlation coefficients of CEUS were 0.195 (p = 0.523), which indicated the absence of a threshold effect in the CEUS assessment. Three pairs of metaregression analyses, with regard to study design (prospective or retrospective), treatment time of patients (before 2012 or after 2012) and CEUS experience of radiologists (more than four years or more than ten years) were performed in order to assess the non-threshold effect. The results of meta-regression indicated that study design, treatment time of patients and experience of radiologists had no strong association with CEUS accuracy (Table 3) . PVT or PVS. Moreover, we assumed that the experience of radiologists who are responsible for performing CEUS and reading CEUS imaging may also affect the diagnostic accuracy. As CEUS examination is operator-dependent and requires specific skills and training (24) , misreading may occur sometimes. Some included studies restricted the interpretation protocol in order to reduce the chance of a misdiagnosis. CEUS was not performed if there were no available trained radiology staff in the study of Garcacriado (25) . More than one experienced examiner was involved in analyzing the CEUS scan in order to avoid misreading in the study performed by Rennert and Zheng (32, 34) . However, most of the studies did not apply the same protocol as above. Thus, we assessed the influence of the radiologists' experience on the diagnostic performance of CEUS. Although metaregression analysis in our study revealed that radiologists' experience has no strong correlation with CEUS accuracy, future studies should not ignore this factor.
There are some limitations in the present meta-analysis. First, the small sample size might influence the statistical power of the individual study and lead to inconclusive and imprecise results. Furthermore, our study assessed the usefulness of CEUS for the detection of all types of vascular complications. Whether CEUS has a high accuracy for the diagnosis of a particular kind of complications is yet to be established. Moreover, the included studies only performed CEUS in cases of suspicious US findings, instead of conducting it in every patient. Thus, the diagnostic yield may be overestimated. This condition further suggested that CEUS should be used in conjunction with US. Many other factors including patient demographics (obesity), types and doses of contrast agents and timing of CEUS evaluation should be taken into consideration. However, no consensus has been reached with regard to these factors, making it impossible to conduct a subgroup analysis in this metaanalysis.
CONCLUSION
Our meta-analysis revealed that CEUS had a high sensitivity and specificity for the Summary receiver operating characteristic curve of CEUS evaluation.
